Patents by Inventor YoungEun HONG

YoungEun HONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230405139
    Abstract: The present invention relates to new antibody-drug conjugates (ADCs) targeting ROR1, active metabolites of such ADCs, methods for preparation of such ADCs, uses for such ADCs in treatment and/or prevention of illnesses, and uses for such ADCs in production of drugs for treatment and/or prevention of diseases, more specifically diseases associated with over-expression of ROR1, for example cancer. More specifically, the present invention relates to an antibody-drug conjugate comprising an antibody that binds to ROR1 or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same.
    Type: Application
    Filed: June 13, 2023
    Publication date: December 21, 2023
    Inventors: Yun-Hee Park, Ho Young Song, Hyun Min Ryu, Sung Min Kim, Ju Yuel Baek, Ji Hye Oh, Nara Han, Hyoung Rae Kim, Kyung Eun Park, Hyeun Joung Lee, Ju Young Lee, Dae Hyuck Kang, Young-Jae Yang, Ji-na You, Yong Zu Kim, Chang Sun Lee, Jeiwook Chae, Jinwon Jung, Juhee Kim, Bora Lee, Daehae Song, Byungje Sung, Donghoon Yeom, Jaehyun Eom, Youngeun Hong, Jinhyung Ahn, Yangsoon Lee, Kyungjin Park, Jiseon Yoo, Minji Park
  • Patent number: 11707533
    Abstract: The present invention relates to new antibody-drug conjugates (ADCs) targeting ROR1, active metabolites of such ADCs, methods for preparation of such ADCs, uses for such ADCs in treatment and/or prevention of illnesses, and uses for such ADCs in production of drugs for treatment and/or prevention of diseases, more specifically diseases associated with over-expression of ROR1, for example cancer. More specifically, the present invention relates to an antibody-drug conjugate comprising an antibody that binds to ROR1 or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same.
    Type: Grant
    Filed: July 27, 2020
    Date of Patent: July 25, 2023
    Assignees: LegoChem Biosciences, Inc., ABL Bio, Inc.
    Inventors: Yun-Hee Park, Ho Young Song, Hyun Min Ryu, Sung Min Kim, Ju Yuel Baek, Ji Hye Oh, Nara Han, Hyoung Rae Kim, Kyung Eun Park, Hyeun Joung Lee, Ju Young Lee, Dae Hyuck Kang, Young-Jae Yang, Ji-Na You, Yong Zu Kim, Chang Sun Lee, Jeiwook Chae, Jinwon Jung, Juhee Kim, Bora Lee, Daehae Song, Byungje Sung, Donghoon Yeom, Jaehyun Eom, Youngeun Hong, Jinhyung Ahn, Yangsoon Lee, Kyungjin Park, Jiseon Yoo, Minji Park
  • Publication number: 20220125944
    Abstract: The present invention relates to a novel compound comprising a galactose trigger moiety and cyclopropabenzindole (CBI), and an antibody-drug conjugate prepared by using same.
    Type: Application
    Filed: March 6, 2020
    Publication date: April 28, 2022
    Inventors: Jinwon JUNG, Juhee KIM, Youngdon Pak, Daehae SONG, Donghoon YEOM, Jaehyun EOM, Youngeun HONG, Bora LEE
  • Publication number: 20210069342
    Abstract: The present invention relates to new antibody-drug conjugates (ADCs) targeting ROR1, active metabolites of such ADCs, methods for preparation of such ADCs, uses for such ADCs in treatment and/or prevention of illnesses, and uses for such ADCs in production of drugs for treatment and/or prevention of diseases, more specifically diseases associated with over-expression of ROR1, for example cancer. More specifically, the present invention relates to an antibody-drug conjugate comprising an antibody that binds to ROR1 or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same.
    Type: Application
    Filed: July 27, 2020
    Publication date: March 11, 2021
    Inventors: Yun Hee Park, Ho Young Song, Hyun Min Ryu, Sung Min Kim, Ju Yuel Baek, Ji Hye Oh, Nara Han, Hyoung Rae Kim, Kyung Eun Park, Hyeun Joung Lee, Ju Young Lee, Dae Hyuck Kang, Young-Jae Yang, Ji-Na You, Yong Zu Kim, Chang Sun Lee, Jeiwook Chae, Jinwon Jung, Juhee Kim, Bora Lee, Daehae Song, Byungje Sung, Donghoon Yeom, Jaehyun Eom, Youngeun Hong, Jinhyung Ahn, Yangsoon Lee, Kyungjin Park, Jiseon Yoo, Minji Park
  • Patent number: 10177206
    Abstract: Disclosed is an organic light emitting display device that may include an anode electrode and an eave structure under a bank layer and spaced apart from each other, a cathode electrode on the bank layer, and an auxiliary electrode under the eave structure and electrically connected with the cathode electrode, wherein the cathode electrode extends to a contact space under the eave structure, and the extending cathode electrode is connected with the auxiliary electrode in the contact space.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: January 8, 2019
    Assignee: LG DISPLAY CO., LTD.
    Inventors: DeukSoo Jung, Yongsun Jo, YoungEun Hong, SungSoo Kim
  • Publication number: 20180097047
    Abstract: Disclosed is an organic light emitting display device that may include an anode electrode and an eave structure under a bank layer and spaced apart from each other, a cathode electrode on the bank layer, and an auxiliary electrode under the eave structure and electrically connected with the cathode electrode, wherein the cathode electrode extends to a contact space under the eave structure, and the extending cathode electrode is connected with the auxiliary electrode in the contact space.
    Type: Application
    Filed: December 2, 2016
    Publication date: April 5, 2018
    Applicant: LG DISPLAY CO., LTD.
    Inventors: DeukSoo JUNG, Yongsun JO, YoungEun HONG, SungSoo KIM